venBio Partners LLC Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$123.6B

Holdings

7

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (7 positions)

#StockSharesValue% PortfolioType
1
PHVSPHARVARIS N V
4,289,304$67.3B54.50%
2
ALMSALUMIS INC
2,787,398$17.1B13.85%
3
HRMYHARMONY BIOSCIENCES HLDGS IN
489,194$16.2B13.14%
4
SLRNACELYRIN INC
3,806,410$9.4B7.61%
5
ALXOALX ONCOLOGY HLDGS INC
9,699,925$6.0B4.89%
6
LYELLYELL IMMUNOPHARMA INC
7,102,190$3.8B3.09%
7
ARTVARTIVA BIOTHERAPEUTICS INC
1,198,975$3.6B2.91%